Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




First European Lab Automation Conference Convenes in Hamburg

By LabMedica International staff writers
Posted on 15 Aug 2011
The first European Lab Automation (ELA) conference and exhibition took place at the Congress Center Hamburg (CCH; Germany) from June 30–July 1, 2011. More...
The congress consisted of ten distinct tracks each addressing a specific application area, but with an underlying theme of automating the technique, equipment, or associated informatics.

With 1,523 attendees and 151 exhibitors and media partners, the feedback was overwhelmingly positive. The combination of ten comprehensive conference tracks and workshops provided useful and relevant scientific content across a range of applications within laboratory automation.

Of particular interest was the world biobanking summit, which included blood banking; standardization; harmonization; bioethics and regulations for global biobanking; and field cancer biobanking. The keynote speakers were Mary-Beth Fisk, vice president of the Texas Blood and Tissue Bank (San Antonio, TX, USA) and Prof. Malcolm Mason from Cardiff University (Wales, United Kingdom).

Mary-Beth Fisk reviewed methods for umbilical cord blood processing/cell isolation, defined technologies for cryoprotection, freezing, and storage of cells. She talked about cord blood-collection modes and outlined current statistical data related to transplantation and other clinical uses for cord blood in regenerative medicine.

Prof. Mason discussed the future of biobanking for cancer. He discussed the balance between accumulating large numbers of samples with good clinical annotation, in the light of encouraging the scientific community to use what is already available.

Some of the vendors who expressed their satisfaction with the conference exhibition included Venomtech (Ramsgate, United Kingdom), TAP Biosystems (Royston, United Kingdom), Thermo Fisher Scientific (Palm Springs, CA, USA), and KBiosystems (Basildon, United Kingdom).

Ken Browne, event organizer and director of Select Biosciences (Sudbury, UK) commented, “We are delighted with the success of the first ELA conference and exhibition and have received some fantastic feedback from vendors and delegates alike.” He continued, “We are aiming to fill the need for a pan-European Automation event, and establish ELA as the forum for combining scientific content with up-to-date technology. As such, we have already booked the date for the second ELA conference and hope to continue its success.” The venue in Hamburg is being booked for next year and the event is scheduled for May 30-31, 2012.

Related Links:

European Lab Automation


New
Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.